APPLICATION
ANDA076368
TYPE
ANDA
ORIGINAL APPROVAL
2004-08-18
LATEST ACTION
2009-06-29
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription
Products
POTASSIUM CHLORIDEPrescription
POTASSIUM CHLORIDE 20MEQ · TABLET, EXTENDED RELEASE · ORAL
POTASSIUM CHLORIDEPrescription
POTASSIUM CHLORIDE 10MEQ · TABLET, EXTENDED RELEASE · ORAL
Approval history
2009-06-29Labeling · Supplement 6AP
2004-08-18OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.